The use of uHear™ to screen for hearing loss in older patients with cancer as part of a comprehensive geriatric assessment

Lycke, Michelle and Debruyne, Philip R. and Lefebvre, Tessa and Martens, Evi and Ketelaars, Lore and Pottel, Hans and van Eygen, Koen and Derijcke, Sofie and Werbrouck, Patrick and Vergauwe, Philippe and Stellamans, Karin and Clarysse, Philippe and Dhooge, Ingeborg and Schofield, Patricia and Boterberg, Tom (2018) The use of uHear™ to screen for hearing loss in older patients with cancer as part of a comprehensive geriatric assessment. Acta Clinica Belgica, 73 (2). pp. 132-138. ISSN 2295-3337

[img] Text
Accepted Version
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (341kB)
Official URL: http://dx.doi.org/10.1080/17843286.2017.1392070

Abstract

Objective: We previously validated uHear™ to screen for hearing loss in older patients with cancer without a known hearing loss, as part of a comprehensive geriatric assessment (CGA). In view of low specificity, we tested a new modified uHear™ scoring system as described by Handzel. Methods: Patients, aged ≥70 years, were evaluated by uHear™ and conventional audiometry, which is considered the gold standard, as part of a CGA. The pass or fail screening cut-off for uHear™ was defined as having ≥2 consecutive hearing grades starting from the moderate– severe threshold zone ranging from 0.5 to 2.0 kHz (modified Handzel-uHear™ scoring system). To accept the modified Handzel-uHear™ as screening tool, it was predefined that the combined sensitivity (S) and specificity (Sp) of the test (S + Sp/2) was at least 80% and that an actual combined (S + Sp)/2 of 90% would be found. Results: Ninety ears (45 subjects) were tested. Of those ears, 24.4% were identified as impaired by conventional audiometry. Modified Handzel-uHear™ identified 26.7% of tested ears as impaired. The combined (S + Sp)/2 of the modified Handzel-uHear™ was calculated as 77.5%, while in previous cohort, this was retrospectively calculated as 94.6%. A new uHear™ scoring system was proposed and tested in current and previous cohort. A (S + Sp)/2 of 80.2 and 78.8%, respectively, were obtained. Conclusion: uHear™ is a feasible tool for use within the CGA and shows promising results. However, further research is warranted to optimize the cut-off method before it could be routinely implemented within geriatric oncology.

Item Type: Journal Article
Keywords: Older Patients with cancer, Comprehensive Geriatric Assessment, hearing loss screening, uHear™
Faculty: ARCHIVED Faculty of Health, Social Care & Education (until September 2018)
Depositing User: Prof Pat Schofield
Date Deposited: 26 Oct 2017 15:19
Last Modified: 14 Nov 2019 16:09
URI: http://arro.anglia.ac.uk/id/eprint/702386

Actions (login required)

Edit Item Edit Item